Oncology Medical News about autoimmune diseases

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Autologous hematopoietic stem cell transplantation (HSCT) for autoimmune diseases: an observational study on 12 years of experience from the European Group for Blood and Marrow Transplantation (EBMT) Working Party on Autoimmune Diseases
Haematologica, 09/25/09

Farge D et al. – This largest cohort studied worldwide shows that autologous HSCT can induce sustained remissions for more than 5 years in patients with severe AD refractory to conventional therapy. AD disease type, rather than transplant techniques, was the most relevant determinant of outcome. Results improved with time and were associated with centre experience. The data support ongoing and planned phase III trials to evaluate the place of autologous HSCT in the treatment strategy for severe AD.

<< Previous
FEIBA prophylaxis in haemophilia patients: a clinical update and...

Next >>
Effects of Transdermal Buprenorphine on Patients-reported...